Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group LSE:RENE London Ordinary Share GB00B0DZML60 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.025p +1.79% 1.425p 1.40p 1.45p 1.425p 1.40p 1.40p 6,933,386 09:09:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -18.2 -0.5 - 45.10

Reneuron Share Discussion Threads

Showing 5526 to 5550 of 5550 messages
Chat Pages: 222  221  220  219  218  217  216  215  214  213  212  211  Older
DateSubjectAuthorDiscuss
18/1/2018
17:24
Added a lot more today @ 1.4...just in case! Cheers
14dragon
18/1/2018
16:28
Possibly post consolidation is a better idea based on my previous (usually loss making experience with consolidations).Good luck whatever you decide.keep us posted AuDigger.
algernon2
18/1/2018
13:09
Lower and lower we go. I agree that consolidation is likely to be followed by dilution but I’m not sure when they will come calling. Am tempted to add some more...but no t sure whether to do it now or post consolidation
audigger
10/1/2018
17:17
I'm LT holder, generally consolidation means rinse & repeat in my experience. More dilution will follow to raise funds....gutted, I thought this was a genuine prospect.....wait for the dilution after consolidation now.
nsk1
10/1/2018
10:28
good job i am not banking on these for my pension!!! cannot believe the share price and then the drop with the consolidation RNS. RBS did the same but they managed to keep the share price relatively the same in real terms.
stewart_25
10/1/2018
10:04
NASDQ at higher price is my bet, but nothing more than a guess!
small crow
10/1/2018
09:58
I do see it later in a year or so. Cash in hand is only expected to see them until the end of Re001 trials and surely they won't want to leave it until then. Hope I'm wrong and they find funding else where.
ps0u3165
10/1/2018
07:34
ps, Perhaps but they are sitting on a fair amount of cash. Why do you think more at this stage rather than later??
small crow
10/1/2018
07:14
I'm expecting another placement after consolidation. At maybe £1.50 it looks better than 1.5P in a year or so.
ps0u3165
05/1/2018
10:04
Price will be 100x more but your share holding will be 100x less. Usually bad news for the share price at least in the short-term. Happened on a couple of shares I have owned and both drifted lower straight after. The value of 1p has nothing to do with the current or proposed share price.
gisjob2
05/1/2018
09:08
How is that possible when the new share price will be 1pence, unless they meant 1 pound
chaudm
05/1/2018
09:03
You'll have fewer shares but they'll be worth more...
small crow
05/1/2018
08:52
So bad news for us? Normally after a consolidation the share price is higher, but looks like it will be lower here, ???
chaudm
05/1/2018
08:49
Consolidation of shares usually means share price down over next few weeks.
rock star
05/1/2018
08:47
Does this mean new shares will 1p each
chaudm
05/1/2018
07:43
More like to fend off being labelled a 1p share.
ps0u3165
05/1/2018
07:14
Consolidation. Could this, in any way, be related to a putative NASDAQ listing???
small crow
29/12/2017
12:31
Yes. Neat parcels.
small crow
29/12/2017
12:24
Bit of new year shifting of stock
bigspuds
21/12/2017
16:20
Same to you stewart and everyone else here too.
algernon2
21/12/2017
15:54
Is 2018 going to be our year? Hopefully some big news and further developments. Good luck to all holders and wishing you all a Very Happy Christmas and a Happy New Year.
stewart_25
19/12/2017
20:51
1. Boston office = NASDAQ quote? 2. "FDA Approves Spark Therapeutics' LUXTURNA(TM) (voretigene neparvovec-rzyl), a One-time Gene Therapy for Patients with Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy" http://www.nasdaq.com/press-release/fda-approves-spark-therapeutics-luxturnatm-voretigene-neparvovecrzyl-a-onetime-gene-therapy-for-20171219-00896
rotors
15/12/2017
11:50
Again - great news - FDA approval is huge and yet the share price barely moves.. So disappointing..
stewart_25
15/12/2017
08:54
Bid above Offer?
small crow
14/12/2017
08:15
Very good news of FDA approval. It's a long game, this one, but IMO at some stage folk are going to start wanting them. As has often been remarked, with their cash and this mcap, an acquisition pretty well gets the IP for free ...... and it's developing nicely. So, while it might be post-2020 before they themselves can realise value, I wouldn't be surprised to see Big Pharma make a move well before then.
small crow
Chat Pages: 222  221  220  219  218  217  216  215  214  213  212  211  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180121 03:02:24